These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2420893)

  • 1. Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression.
    Matis LA; Shu S; Groves ES; Zinn S; Chou T; Kruisbeek AM; Rosenstein M; Rosenberg SA
    J Immunol; 1986 May; 136(9):3496-501. PubMed ID: 2420893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunotherapy of syngeneic murine leukemia is enhanced by the combination of recombinant IFN-gamma and a tumor-specific cytotoxic T cell clone.
    de Graaf PW; Horak E; Bookman MA
    J Immunol; 1988 Apr; 140(8):2853-7. PubMed ID: 3128613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-driven T cell clones can proliferate in vivo, eradicate disseminated leukemia, and provide specific immunologic memory.
    Klarnet JP; Matis LA; Kern DE; Mizuno MT; Peace DJ; Thompson JA; Greenberg PD; Cheever MA
    J Immunol; 1987 Jun; 138(11):4012-7. PubMed ID: 3108381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
    Klarnet JP; Kern DE; Dower SK; Matis LA; Cheever MA; Greenberg PD
    J Immunol; 1989 Apr; 142(7):2187-91. PubMed ID: 2466890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Il-4 is an endogenous T cell growth factor during the immune response to a syngeneic retrovirus-induced tumor.
    Kern DE; Peace DJ; Klarnet JP; Cheever MA; Greenberg PD
    J Immunol; 1988 Oct; 141(8):2824-30. PubMed ID: 2459230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
    Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
    J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloned helper and cytotoxic T lymphocytes as effector cells in adoptive immunotherapy of murine leukemia.
    Bookman MA; Horak E; de Graaf PW
    Prog Clin Biol Res; 1989; 288():141-9. PubMed ID: 2524069
    [No Abstract]   [Full Text] [Related]  

  • 9. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.
    Hardt C; Diamantstein T; Wagner H
    Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
    Rosenstein M; Rosenberg SA
    J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
    Shu S; Rosenberg SA
    J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy of murine leukemia with cyclophosphamide and immune Lyt-2+ cells: cytolytic T cells can mediate eradication of disseminated leukemia.
    Greenberg PD
    J Immunol; 1986 Mar; 136(5):1917-22. PubMed ID: 3485134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for T cell recognition and elimination of retrovirally-transformed cells.
    Greenberg P; Klarnet J; Kern D; Okuno K; Riddell S; Cheever M
    Princess Takamatsu Symp; 1988; 19():287-301. PubMed ID: 2479634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones.
    Andrew ME; Braciale VL; Braciale TJ
    J Immunol; 1984 Feb; 132(2):839-44. PubMed ID: 6418812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.
    Andrew ME; Churilla AM; Malek TR; Braciale VL; Braciale TJ
    J Immunol; 1985 Feb; 134(2):920-5. PubMed ID: 3917480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
    Isakov N; Altman A
    J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A; Shiku H; Nakayama E
    J Immunol; 1993 Jun; 150(11):4900-10. PubMed ID: 8496592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
    Thompson JA; Peace DJ; Klarnet JP; Kern DE; Greenberg PD; Cheever MA
    J Immunol; 1986 Dec; 137(11):3675-80. PubMed ID: 3491145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.